Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Other Working Capital Changes (2018)

Ocugen's (OCGN) quarterly Other Working Capital Changes came in at -$317000.0 in Q1 2026, down 62.56% YoY from -$846780.8 in Q1 2025, and up 75.93% on a QoQ basis from -$1.3 million in Q4 2025.

Analysis

Ocugen (OCGN) Other Working Capital Changes (2018) Analysis & Trends

Ocugen (OCGN) has 7 years of Other Working Capital Changes data on file, last reported at -$317000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes fell 62.56% year-over-year to -$317000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 51.74% YoY) and the FY2025 annual result came in at -$1.2 million, down 47.3% from the prior year.
  • Other Working Capital Changes grew to -$317000.0 in Q1 2026, from -$1.3 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.0 million in Q1 2025 to a low of -$1.8 million in Q3 2022.
  • A 5-year average of $198705.9 and a median of $117000.0 in 2024 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 3350.0% — and 2025, when it surged 273.67%.
  • Tracing OCGN's Other Working Capital Changes over 5 years: stood at -$122000.0 in 2022, then slipped by 10.66% to -$135000.0 in 2023, then slumped by 60.0% to -$216000.0 in 2024, then tumbled by 509.72% to -$1.3 million in 2025, then surged by 75.93% to -$317000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$317000.0 (Q1 2026), -$1.3 million (Q4 2025), and $686000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ocugen 458.91 Mn 358.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 10.00 Mn
Mar 31, 2018 10.00 Mn